Oncothyreon Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Oncothyreon

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Jibacoa who wrote (643)	5/6/1999 6:16:00 PM
From: Garry K.	Read Replies (1) of 2344

Assuming that the news is very positive at the ASCO convention, and we see a "significant" spike in share price as a result (plus possible positive press or articles), would it not be safe to say that there would be a gradual erosion in share price once the story cools off, and the market waits for approximately 12 months for Phase III news? I have been long on this stock for well over 2 years, and will continue to be. However, I will be inclined to sell a good portion of my holdings immediately after a runup. News seems to be the catalyst for biotechs like Biomira -- once the news drys up, so does the share price. I feel there may be ample time to buy back in at lower prices if we see an initial runup this month. Some input from the thread would be appreciated on these thoughts. Good luck to all. Garry

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next